Henan Cancer Hospital
Clinical trials sponsored by Henan Cancer Hospital, explained in plain language.
-
New drug aims to shield lung cancer patients from chemo side effects
Disease control ENROLLING_BY_INVITATIONThis study tests whether a drug called trilaciclib can prevent bone marrow suppression (low blood cell counts) caused by platinum chemotherapy in people with advanced non-small cell lung cancer. About 41 participants will receive trilaciclib before each chemo session. The main go…
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
New cocktail therapy shows promise for tough stomach cancers
Disease control OngoingThis study tests a combination of three drugs (fruquintinib, sintilimab, and SOX chemotherapy) in 42 people with advanced stomach cancer that has spread but might still be removable. The goal is to shrink the tumors enough to allow complete surgical removal. The main focus is on …
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New hope for Hodgkin's: immune-boosting drug plus chemo shows promise
Disease control OngoingThis study tests a new combination of the immunotherapy drug camrelizumab with standard chemotherapy (AVD) as a first treatment for people with advanced classical Hodgkin's lymphoma. The goal is to see how well the combination works at shrinking or eliminating tumors. The study i…
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC